Methods and compositions for stimulating and inhibiting tgf-.beta. activity
CA 2590837 A1 · Owner: Schultz-Cherry, Stacey · Inventors: Murphy-Ullrich, Joanne E.; Schultz-Cherry, Stacey; Roberts, David D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method of stimulating TGF-.beta. activity comprising , contacting latent TGF-.beta. with an amount of TSP or an activating peptide from TSP , effective to convert latent TGF-.beta. to active TGF-.beta.. Also provided is a method of , inhibiting the stimulation of TGF-.beta. activity comprising contacting , latent TGF-.beta. with a ligand specific for TSP effective to bind TSP and prevent activation of TGF-.beta. , or an amount of an inhibiting peptide having a sequence that corresponds to a sequence , of four consecutive amino acids of TSP effective to inhibit the conversion of latent TGF-.beta. , to active TGF-.beta.. The invention also provides a method of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 12, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 12, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 12, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.